E75.244 Niemann-Pick disease type A/B

Name of the Condition

• Niemann-Pick disease type A/B (ICD-10 Code: E75.244)

Summary

Niemann-Pick disease type A/B is a rare inherited lysosomal storage disorder characterized by the abnormal accumulation of sphingomyelin and cholesterol in cells, affecting organs such as the liver, spleen, and nervous system. It is a subtype of Niemann-Pick disease, part of a broader group of sphingolipid metabolism disorders, and presents with variable clinical manifestations. The condition combines features of both type A and type B, with potential for early-onset neurological involvement and progressive organ dysfunction.

Causes

This disorder results from mutations in the SMPD1 gene, which encodes the enzyme acid sphingomyelinase. These mutations impair the enzyme's ability to break down sphingomyelin, leading to its buildup in tissues. Inheritance is autosomal recessive, meaning both copies of the gene must be mutated for the condition to manifest.

Risk Factors

• Family history of Niemann-Pick disease type A/B or related lysosomal storage disorders.
• Consanguineous relationships, increasing the likelihood of recessive gene mutations.
• Ethnic backgrounds with higher carrier frequencies for SMPD1 mutations.

Symptoms

• Enlarged liver and spleen (hepatosplenomegaly).
• Progressive neurological decline, including developmental delay or regression.
• Muscle weakness, hypotonia, or spasticity.
• Seizures or abnormal eye movements.
• Loss of motor skills or speech.
• Respiratory difficulties, such as recurrent infections or shortness of breath.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Physical examination may reveal hepatosplenomegaly and neurological signs. Laboratory tests include measuring acid sphingomyelinase activity in white blood cells or skin fibroblasts. Genetic testing confirms mutations in the SMPD1 gene. Imaging studies, such as MRI, may assess neurological involvement, while organ function tests evaluate liver and lung status.

Treatment Options

Treatment is supportive and focuses on managing symptoms and complications. This may include enzyme replacement therapy, bone marrow transplantation, or hematopoietic stem cell transplantation for select cases. Medications address specific symptoms, such as seizures or respiratory issues. Nutritional support and physical therapy help maintain function. Regular monitoring of organ function and neurological status is essential.

Prognosis and Follow-Up

Prognosis varies depending on the severity of neurological involvement and organ dysfunction. Early-onset cases with significant neurological decline may have a shorter lifespan, while milder forms may allow for longer survival with progressive organ complications. Follow-up involves regular assessments of liver, spleen, lung, and neurological function. Genetic counseling is recommended for families to discuss inheritance risks.

Complications

• Progressive neurological deterioration, including loss of motor and cognitive function.
• Severe respiratory failure due to lung involvement.
• Liver failure or portal hypertension from hepatic damage.
• Increased susceptibility to infections.
• Growth failure and nutritional deficiencies.

Lifestyle & Prevention

• Genetic counseling for families with a history of the condition.
• Prenatal testing or carrier screening for at-risk individuals.
• Supportive care to manage symptoms, such as respiratory therapy or physical rehabilitation.
• Monitoring for organ dysfunction to address complications early.

When to Seek Professional Help

Seek medical attention if symptoms such as unexplained hepatosplenomegaly, developmental regression, seizures, or respiratory difficulties occur. Prompt evaluation is critical for early diagnosis and management. Consult a specialist in metabolic or genetic disorders for comprehensive care.

Tips for Medical Coders

When coding for Niemann-Pick disease type A/B (E75.244), ensure documentation specifies the subtype and confirms clinical features consistent with the diagnosis. Verify that the code aligns with the patient's documented symptoms, genetic testing results, or enzyme activity levels. Accurate coding requires clear differentiation from other Niemann-Pick subtypes (e.g., type A or B alone) based on clinical presentation.